| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.4 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.043 | 0.4 |